Leukocyte Trafficking Via Lymphatic Vessels in Atherosclerosis

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2021 Jun 2

PMID 34072313

Citations 7

Authors

Kim Pin Yeo

Hwee Ying Lim

Veronique Angeli

Affiliations

Soon will be listed here.

Abstract

In recent years, lymphatic vessels have received increasing attention and our understanding of their development and functional roles in health and diseases has greatly improved. It has become clear that lymphatic vessels are critically involved in acute and chronic inflammation and its resolution by supporting the transport of immune cells, fluid, and macromolecules. As we will discuss in this review, the involvement of lymphatic vessels has been uncovered in atherosclerosis, a chronic inflammatory disease of medium- and large-sized arteries causing deadly cardiovascular complications worldwide. The progression of atherosclerosis is associated with morphological and functional alterations in lymphatic vessels draining the diseased artery. These defects in the lymphatic vasculature impact the inflammatory response in atherosclerosis by affecting immune cell trafficking, lymphoid neogenesis, and clearance of macromolecules in the arterial wall. Based on these new findings, we propose that targeting lymphatic function could be considered in conjunction with existing drugs as a treatment option for atherosclerosis.

Citing Articles

Preliminary findings on the absence of PEPITEM release in B cells isolated from Saudi donors: implications for expanded population studies.

Alassiri M, Alanazi A, Barhoumi T, Alrfaei B, Alanazi M, Rashid M Am J Clin Exp Immunol. 2024; 13(5):215-225.

PMID: 39583342 PMC: 11578804. DOI: 10.62347/XNNO3661.

Characterization of Atherosclerotic Mice Reveals a Sex-Dependent Susceptibility to Plaque Calcification but No Major Changes in the Lymphatics in the Arterial Wall.

Christ C, Ocskay Z, Kovacs G, Jakus Z Int J Mol Sci. 2024; 25(7).

PMID: 38612867 PMC: 11012298. DOI: 10.3390/ijms25074046.

Abnormal Lymphatic Sphingosine-1-Phosphate Signaling Aggravates Lymphatic Dysfunction and Tissue Inflammation.

Kim D, Tian W, Wu T, Xiang M, Vinh R, Chang J Circulation. 2023; 148(16):1231-1249.

PMID: 37609838 PMC: 10592179. DOI: 10.1161/CIRCULATIONAHA.123.064181.

Abnormal lymphatic S1P signaling aggravates lymphatic dysfunction and tissue inflammation.

Kim D, Tian W, Wu T, Xiang M, Vinh R, Chang J medRxiv. 2023; .

PMID: 37398237 PMC: 10312855. DOI: 10.1101/2023.06.08.23291175.

Differential regulation of lymphatic junctional morphology and the potential effects on cardiovascular diseases.

Peluzzo A, Bkhache M, Do L, Autieri M, Liu X Front Physiol. 2023; 14:1198052.

PMID: 37187962 PMC: 10175597. DOI: 10.3389/fphys.2023.1198052.

References

Roselaar S, Daugherty A . Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J Lipid Res. 1998; 39(9):1740-3. View

Dal Canto A, Swanson P, OGuin A, Speck S, Virgin H . IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site. J Clin Invest. 2001; 107(2):R15-22. PMC: 199178. DOI: 10.1172/JCI11540. View

Mohanta S, Yin C, Peng L, Srikakulapu P, Bontha V, Hu D . Artery tertiary lymphoid organs contribute to innate and adaptive immune responses in advanced mouse atherosclerosis. Circ Res. 2014; 114(11):1772-87. DOI: 10.1161/CIRCRESAHA.114.301137. View

Nakata Y, Shionoya S . Vascular lesions due to obstruction of the vasa vasorum. Nature. 2010; 212(5067):1258-9. DOI: 10.1038/2121258a0. View

Thaunat O, Kerjaschki D, Nicoletti A . Is defective lymphatic drainage a trigger for lymphoid neogenesis?. Trends Immunol. 2006; 27(10):441-5. DOI: 10.1016/j.it.2006.08.003. View

Srinivasan R, Escobedo N, Yang Y, Interiano A, Dillard M, Finkelstein D . The Prox1-Vegfr3 feedback loop maintains the identity and the number of lymphatic endothelial cell progenitors. Genes Dev. 2014; 28(19):2175-87. PMC: 4180978. DOI: 10.1101/gad.216226.113. View

Weber C, Noels H . Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011; 17(11):1410-22. DOI: 10.1038/nm.2538. View

Kraft J, Blomgran R, Lundgaard I, Quiding-Jarbrink M, Bromberg J, Borgeson E . Specialized Pro-Resolving Mediators and the Lymphatic System. Int J Mol Sci. 2021; 22(5). PMC: 7963193. DOI: 10.3390/ijms22052750. View

Douna H, Kuiper J . Novel B-cell subsets in atherosclerosis. Curr Opin Lipidol. 2016; 27(5):493-8. DOI: 10.1097/MOL.0000000000000335. View

10.

Randolph G, Ivanov S, Zinselmeyer B, Scallan J . The Lymphatic System: Integral Roles in Immunity. Annu Rev Immunol. 2016; 35:31-52. PMC: 5551392. DOI: 10.1146/annurev-immunol-041015-055354. View

11.

Debes G, Arnold C, Young A, Krautwald S, Lipp M, Hay J . Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat Immunol. 2005; 6(9):889-94. PMC: 2144916. DOI: 10.1038/ni1238. View

12.

Nielsen L . Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux. Atherosclerosis. 1999; 143(2):229-43. DOI: 10.1016/s0021-9150(99)00064-7. View

13.

Randolph G . Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis. Curr Opin Lipidol. 2008; 19(5):462-8. PMC: 2652166. DOI: 10.1097/MOL.0b013e32830d5f09. View

14.

Heistad D, Marcus M, Larsen G, Armstrong M . Role of vasa vasorum in nourishment of the aortic wall. Am J Physiol. 1981; 240(5):H781-7. DOI: 10.1152/ajpheart.1981.240.5.H781. View

15.

Mohler 3rd E, Ballantyne C, Davidson M, Hanefeld M, Ruilope L, Johnson J . The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized,.... J Am Coll Cardiol. 2008; 51(17):1632-41. DOI: 10.1016/j.jacc.2007.11.079. View

16.

Baluk P, Tammela T, Ator E, Lyubynska N, Achen M, Hicklin D . Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest. 2005; 115(2):247-57. PMC: 544601. DOI: 10.1172/JCI22037. View

17.

Singla B, Lin H, Ahn W, White J, Csanyi G . Oxidatively Modified LDL Suppresses Lymphangiogenesis via CD36 Signaling. Antioxidants (Basel). 2021; 10(2). PMC: 7926875. DOI: 10.3390/antiox10020331. View

18.

Bates D, Harper S . Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol. 2003; 39(4-5):225-37. DOI: 10.1016/s1537-1891(03)00011-9. View

19.

Maiellaro K, Taylor W . The role of the adventitia in vascular inflammation. Cardiovasc Res. 2007; 75(4):640-8. PMC: 3263364. DOI: 10.1016/j.cardiores.2007.06.023. View

20.

BARKER S, Tilling L, Miller G, Beesley J, Fleetwood G, Stavri G . The adventitia and atherogenesis: removal initiates intimal proliferation in the rabbit which regresses on generation of a 'neoadventitia'. Atherosclerosis. 1994; 105(2):131-44. DOI: 10.1016/0021-9150(94)90043-4. View